global research for global action
DESCRIPTION
Global Research for Global Action. Prof. Martin Prince. Centre for Global Mental Health King’s College London [email protected]. Where do older people live?. In 1950, just over half of the world’s older population lived in less developed regions By 2050, the proportion will be 80%. - PowerPoint PPT PresentationTRANSCRIPT
Global Research for
Global Action
Centre for Global Mental HealthKing’s College [email protected]
Prof. Martin Prince
Where do older people live?
In 1950, just over half of the world’s older population lived in less developed regions
By 2050, the proportion will be 80%
Discourses around global ageing
“Ageing is a development issue. Healthy older persons are a resource for their families, their communities and the economy” (WHO Brasilia Declaration on Ageing, 1996)
“Global aging is the dominant threat to global economic stability - without sweeping changes to age-related public spending, sovereign debt will soon become unsustainable” (Standard and Poor’s – Global Aging 2010: an irreversible truth)
Ageing and public health What is different about old age?
Degenerative disorders – stroke, dementia Complex comorbidities Disability and needs for care Fragile income security and social protection
Why do older people matter? Account for the majority of disease burden and cost
(health and societal) Underserved
Major Challenges? Access to effective, age-appropriate healthcare Diminishing/ meeting long-term care needs
10/66 DRG research agenda
• Pilot studies (1999-2002)– Development and validation of culture and education-fair
dementia diagnosis– Preliminary data on care arrangements
• Population surveys – baseline phase (2003-2009)– Prevalence of dementia and other chronic diseases– Impact: disability, dependency, economic cost– Access to services– Nested RCT of ‘Helping carers to care’ caregiver intervention
• Incidence phase (2008-2010)– Incidence (dementia, stroke, mortality)– Risk factors– Course and outcome of dementia/ Mild Cognitive Impairment
10
10
105
13
15
35
3
13
Methods/ reviewsValidationDementia descriptiveDementia aetiologyBPSD - clinical CaregivingOther chronic diseasesMortalityHealth care/ policyIntervention
10/66 DRG Publications by topic
www.alz.co.uk/1066
Prevalence and ‘numbers’
Developed/ developing country differences
0
5
10
15
20
25
30
35
60- 70- 80- 90Age
% p
reva
lenc
e EURODEMIbadan, NigeriaBallabgarh, India
Prevalence studies worldwide - 2004
Prevalence of 10/66 and DSM IV Dementia
0
5
10
15
20
%
DSMIV
DSMIV
1066
Rodriguez et al for 10/66, Lancet 2008
So is it 8-10% or <1%?
Cross-cultural development, calibration and validation (Prince et al Lancet 2003)
In Cuba, better validity than DSM-IV against local clinician diagnosis (Prince et al, BMC Public Health 2008)
Strong predictive validity in Chennai, India after three year follow-up (Jotheeswaran et al, ADAD 2010)
10/66 algorithm validity
Needs for care at baseline and follow-up – 10/66 Dementia cases
0%10%20%30%40%50%60%70%80%90%
100%
%
much caresome careno care
Incidence phase (n=13,000)
• Sites– Cuba, DR, Venezuela,
Mexico, Peru, China• Outcomes
– Dementia, Stroke, Dependence, Mortality
• Aetiology• Cardiovascular risk (BP/
smoking/ fasting glucose/ cholesterol)
• Diet (anaemia, B12, folate, subclinical hypothyrodism, albumin, anthropometry)
• Developmental factors• APOE and other genetic
factors
Comparing incidence according to 10/66 and DSM-IV criteria
01020304050Incidence/ 1000 PYR
Cuba DR
Venez
uela
Peru (u
rb)
Peru (r
ur)
Mexico
(urb
)
Mexico
(rur)
China (urb
)
China (rur)
DSMIV
DSMIV
1066
Directly standardised incidence rates (age-specific person years - EURODEM incidence pooled analysis)
Site 10/66 Dementiaincidence/ 1000 pyr
Cuba 21.9 (19.0-25.1)Dominican Republic 24.1 (20.3-28.5)
Peru, urban 20.1 (15.3-25.9)Peru, rural 22.8 (16.5-30.8)Venezuela 40.1 (35.0-45.8)Mexico, urban 21.3 (16.1-27.7)
Mexico, rural 50.7 (41.7-61.0)China, urban 31.2 (25.8-37.1)China, rural 37.5 (31.5-44.1)
DSM-III-R incidence/ 1000 pyr
EURODEM 18.4
Mortality among people with dementia, by site
Site Mortality rate (per 1000 person years)
Age and sex adjusted mortality hazard ratiosNo
dementiaDementia cases
Cuba 44.8 195.4 3.20 (2.61-3.92)Dominican Republic 54.5 148.3 2.22 (1.75-2.81)Peru, urban 18.7 139.3 5.69 (3.33-9.73)Peru, rural 28.9 59.5 1.74 (0.68-4.44)Venezuela 24.3 98.4 2.27 (1.42-3.62)Mexico, urban 31.6 114.4 2.70 (1.56-4.67)Mexico, rural 36.6 89.7 1.56 (0.94-2.59)China, urban 40.7 168.1 3.02 (2.13-4.28)China, rural 57.0 216.1 3.59 (2.47-5.21)India, urban 62.5 171.6 2.33 (1.48-3.67)
Pooled meta-analysed effect
2.77 (2.47-3.10)
• Launched World Alzheimer Day, September 21st, New York, 2009– Prevalence– Numbers– Impact– Action
Prof Martin PrinceInstitute of PsychiatryKing’s College London, UK
Prevalence of dementia, by region
0
1
2
3
4
5
6
7
8
9S
tand
ardi
sed
prev
alen
ce (%
)
Increase in numbers of people with dementia, by development status
ADI World Alzheimer Report 2009, Eds Prince & Jackson
Promoting lifelong physical health – opportunities for prevention
• Early life– Education (?nutrition, growth,
neurodevelopment)• Mid to late-life
– Cardiovascular disease and its risk factors, mental stimulation, physical activity, depression
• Late-life– ? Undernutrition (micronutrient deficiency and
anaemia)
PRs* for association between skull circumference (largest vs. smallest quarters) and 10/66 dementia
* Controlling for age, gender, education and family history of dementia
theta.1 101
Combined
CubaDRPeru UPeru RVenezuelaMexico UMexico RChina UChina RIndia UIndia R
0.75 (0.63-0.89)
Sociodemographic and socioeconomic/ cognitive reserve risk factors for incident 10/66 dementia
Risk factor RR* 95% CI HeterogeneityHiggins I2
Base model (mutually adjusted)Age 1.67 1.56-1.79 49 (0-76)Sex (m vs f) 0.72 0.61-0.84 25 (0-64)Education (per level) 0.89 0.81-0.97 50 (0-77)Lower occupation attainment (per level)
1.04 0.95-1.13 0 (0-65)
More assets (per asset)
0.93 0.88-1.00 63 (24-82)
Extensions to base model (adjusted for base model but not each other)Literacy 0.68 0.55-0.84 53 (1-78)Animal naming (per word)
0.93 0.91-0.94 61 (19-81)
Luria (Fist-Edge-Palm) – higher score worse performance
1.28 1.18-1.38 76 (54-88)
* Hazard ratio from proportional hazards competing risk regression
An index of the quality of public healthcare – detection and control of hypertension
Detection Control Detected and controlled
GoodPeru (rural) 97% 93% 90%Peru (urban) 93% 78% 73%Puerto Rico 91% 65% 58%ModerateMexico (urban) 80% 55% 44%Venezuela 83% 50% 42%DR 82% 48% 39%Mexico (rural) 73% 52% 38%China (urban) 79% 45% 36%PoorS Africa 82% 32% 24%Cuba 70% 34% 24%India (rural) 43% 43% 18%India (urban) 44% 37% 16%China (rural) 51% 5% 3%
Prince et al, Journal of Hypertension, 2011
Undernutrition – associations with mortality, incident dependence and dementia
Pooled RR(95% CI)
Heterogeneity(95% CI)
Incident dementia 1
1.22(0.91-1.61)
0%(0-68)
Incident dependence 1
1.11(1.08-1.14)
18%(0-60)
Mortality 2 1.81(1.54-2.13)
68% (39-84)
Mortality among people with dementia 3
1.60(1.27-2.02)
44%(0-76)
1 – controlling for age, sex and education
2 – controlling for age, sex, education, depression, dementia, stroke and number of physical impairments
3 – controlling for age, sex, education and dementia severity
Numbers of prevalence studies by year of data collection
high incom e countrymiddle or low income country
Study location
1980
1982
1984
1986
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
Year of data collection
0
4
8
12
Num
ber o
f stu
dies
• World Alzheimer Day, September 21st, London, 2010– Global Societal Economic
cost– $604bn– 1% of GDP– Equivalent to world’s 18th
largest economy– Larger than the annual
turnover of Walmart
Anders WimoKarolinska Institute, SwedenMartin PrinceKing’s College London, UK
Relative impact of different health conditions, across 10/66 centres, on disability and dependence
Health condition/ impairment Mean population attributable fraction(Dependence)
Mean population attributable fraction(Disability)
1. Dementia 36.0% 25.1%2. Limb paralysis/ weakness 11.9% 10.5%3. Stroke 8.7% 11.4%4. Depression 6.5% 8.3%5. Visual impairment 5.4% 6.8%6. Arthritis 2.6% 9.9%
Sousa et al, Lancet, 2009; BMC Geriatrics 2010
Prioritisation – research into chronic diseases
0 5 10 15
% contribution to years lived with disability
100000
200000
300000
400000
500000
600000
700000
rese
arch
pub
licat
ions
in la
st 1
0 ye
ars
DementiaStroke
Arthritis
Mental disorders
Heart disease
Cancer
0 10 20 30
% contribution to years of life lost
100000
200000
300000
400000
500000
600000
700000
publ
icat
ions
in la
st 1
0 ye
ars
DeafnessStrokeDementia
ArthritisDiabetes
Blindness
Mental disorders
Heart disease
Cancer
How do we prioritise chronic diseases in high income countries?
Research spend (US NIH, 2008)
Healthcare spend (UK NHS)
Cancer $5.6bn £2.1bn
Cardiovascular disease
$2.0bn £4.3bn
Stroke $0.3bn £2.3bn
Dementia $0.4bn £1.4bn
Dementia UK Results
Economic cost of dementia
683,000 people with dementia1.7 million by 2050
Total costs £17 billion
Costs per person
Average £25,472
Mild dementia (community) £14,540Moderate dementia (Community) £20,355
People in care homes £31,263
8%
15%
36%
41%
Health serviceCommunity careInformal careCare homes
Distribution of costs by sector
Long term care and social protection for older people
Long-term care policy
WHO report (2002)• each community should determine
– the types and levels of assistance needed by older people and their carers
– the eligibility for and financing of long-term care support.
• In practice, governments– Do not provide or finance long-term care– Lack comprehensive policies and plans
Social protection legislation in India
“Old age has become a major social challenge and there is need to give more attention to care and protection of older persons. Many older persons . . . are now forced to spend their twilight years all alone and are exposed to emotional neglect and lack of physical and financial support”.Government of India (2007),
“With the joint family system withering away, the elderly are being abandoned. This has been done deliberately as they (the children) have a lot of resources which the old people do not have.” Social Justice Minister, Meira Kumar
Social protection for people with dementia in India (10/66 DRG)
Urban Chennai Rural Vellore
Pension 13.3% 26.9%
Money from family
28.0% 44.4%
Disability pension
2.7% 0.0%
Food insecurity 28.0% 17.6%
No children available locally
9.3% 7.5%
More carrot, less stick….
1. Universal non-means tested ‘social’ pensions
2. Access to disability benefits for people with dementia
3. Caregiver benefits4. Incentivise family care5. Provide basic information, training and
support for caregivers in the community
Intervention - the problem
• Dementia is a hidden problem (demand)
• Little awareness• Not medicalised• People do not seek help
• Health services do not meet the needs of older people (supply)
• Few specialists• Clinic based service - no
home assessment/ care• No continuing care• ‘Out of pocket’ expenses
Prince et al, World Psychiatry, 2007
Equity in delivery of healthcare - predictors of health service use in the last three months
Exposure Meta-analysed PR for association with service use
Age (per year) 0.99 (0.98-1.00)Male sex 0.93 (0.91-0.96)
Education 1.03 (1.01-1.05)Assets 1.08 (1.01-1.17)Health insurance 1.27 (1.16-1.38)In receipt of a pension 1.09 (1.04-1.14)
Physical illness/ impairments
1.37 (1.26-1.49)
ICD 10 depression 1.27 (1.07-1.38)Dementia 0.93 (0.90-0.97)
Albanese et al, BMC Health Services Research 2011
Prevalence of service use varied between 6% and 82% by siteHealth and demographic variables did not explain this variation? Out-of-pocket expenses at ecological (health system) level
Medical help-seeking by people with dementia and their carers
010203040506070
%
Carer noted MIBPSDSMI
Components of care e.g. …. Helping Carers to Care
• Use what there is– Extended role for existing
outreach services– Families
• ‘Low level’ interventions– 5 sessions in 8 weeks– Increase awareness and
understanding – Mobilise support
networks, improve family cohesion
– Basic management strategies in the home Dias et al PLOS One, Guerra et al
Rev Braz Psych; Gavrilova et al IJGP
Packages of care for dementia
• Casefinding• Brief diagnostic screening assessment• Making the diagnosis well – information
and support• Attention to physical comorbidity• Carer interventions (carer strain)• Cognitive stimulation• Non-pharmacological interventions for
behavioural and psychological symptoms
Prince et al, PLOS Medicine 2010Dua et al, PLOS Medicine 2011
VERTICAL (HEALTH CONDITIONS)• Dementia• Stroke• Parkinson’s disease• Depression• Arthritis and other limb
conditions• Anaemia
HORIZONTAL(IMPAIRMENTS)• Communication• Disorientation• Behaviour disturbance• Sleep disturbance• Immobility• Incontinence• Nutrition/ Hydration• Caregiver knowledge• Caregiver strain
Horizontal vs. vertical approachers
Conclusions• The world is facing a new epidemic of
unprecedented proportions• Its effects will be felt particularly in low and
middle income countries - currently least prepared to meet the challenge
• Societal costs will rise inexorably, driven by the increasing need for long term care
• Time for action– Scalable models of evidence-based clinical care to
close the treatment gap– Progressive fiscal and social policy – long-term care– Prevention– Continuous monitoring of key indicators
• Alzheimer’s Disease International• The 10/66 Dementia Research Group in 12
countries: – Juan Llibre Rodriguez, Daisy Acosta, Yueqin Huang,
Aquiles Salas, Ana Luisa Sosa, Mariella Guerra, Ivonne Jimenez, JD Williams, KS Jacob, Richard Uwakwe, Malan Heyns
• Our funders– The Wellcome Trust– US Alzheimer’s Association– World Health Organisation
• The London team– Cleusa Ferri, Renata Sousa, Emiliano Albanese, Michael
Dewey, Rob Stewartwww.alz.co.uk/[email protected]
My thanks to